Loncar China BioPharma ETF (CHNA) |
| 13.53 -0.01 (-0.07%) 10-17 15:51 |
| Open: | 14.3 |
| High: | 14.3 |
| Low: | 13.53 |
| Volume: | 9 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 22.89 |
| 52w Low: | 9.76966 |
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 24 Apr 2025
CHNA Stock Price, News & Analysis | Loncar China BioPharma ETF - Stock Titan
Wed, 16 Aug 2023
SMMT | Summit Therapeutics Inc. Common Stock Data, Price & News - Quiver Quantitative
Wed, 22 Mar 2023
Healthcare Stocks List 2026: Best Publicly Traded Companies - Bullish Bears
Mon, 09 Jan 2023
China ETFs in Last Week’s Top Performing ETFs - ETF Database
Wed, 26 Feb 2020
ETF Stocks 2026: Complete List of Exchange Traded Funds - Bullish Bears
Fri, 10 Aug 2018
Chinese biotech and pharmaceuticals ETF - ETF Stream
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
